SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-23-003334
Filing Date
2023-10-16
Accepted
2023-10-16 16:25:03
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-3 zk2330374.htm F-3 707246
2 EXHIBIT 1.2 exhibit_1-2.htm EX-1 262638
3 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 326106
4 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 25763
5 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 29854
6 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2833
7 FILING FEES TABLE exhibit_107.htm EX-FILING FEES 69410
8 image0.jpg GRAPHIC 74194
9 image00001.jpg GRAPHIC 99674
10 image00002.jpg GRAPHIC 28720
  Complete submission text file 0001178913-23-003334.txt   1704152
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-275002 | Film No.: 231327582
SIC: 2834 Pharmaceutical Preparations